Ads
related to: severe asthma treatments- Pay As Little As $0
Get Information About A Savings
Program & Learn If You Are Eligible
- Sign Up For Email Updates
Receive Personalized Resources For
Your Asthma Journey, Sign Up.
- What Is E-Asthma?
Visit The Official Patient Site To
Learn About Your Asthma Condition.
- Find An Asthma Specialist
Take Control Of Your Asthma
Condition & Find A Doctor Near You.
- Patient Support Tools
Access Different Asthma Resources
That Are Available To You.
- Self-Injection Option
View Resources & Frequent Questions
About This Self-Admin Injection.
- Pay As Little As $0
Search results
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 5 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via Yahoo Finance· 4 days agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 6 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 6 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial — 2nd Update
Morningstar· 6 days agoGSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds ...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 6 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 4 days agotreatment-emergent adverse event (TEAE), with a higher incidence in the rilzabrutinib group versus...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 6 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a ...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 6 days agoThe two randomised, multi-centre, placebo-controlled trials investigated depemokimab in adults and adolescents with severe asthma with type 2...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 6 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
Ads
related to: severe asthma treatments